Literature DB >> 15966272

Hypnic headache responsive to indomethacin: second Italian case.

Maria Gabriella Buzzi1, Daniela Cologno, Rita Formisano, Carlo Caltagirone.   

Abstract

We report a case of hypnic headache (HH) fulfilling the criteria proposed by the revised IHS headache classification and rapidly responsive to indomethacin. The patient is a 70-year-old housewife who presented with a 7-year history of strictly nocturnal headache attacks. The headache occurred every night with a frequency of 1 to 2 attacks occurring between 03.00 and 04.00 a.m. Indomethacin was prescribed at a daily dose of 150 mg/day for 30 days and tapered down in 15 days. Pain did not occur thereafter and at follow up, nine months after discontinuation of the drug, the patient was still pain-free with no relapses. This is the second Italian HH patient responsive to indomethacin, indicating that indomethacin may be a useful alternative treatment in HH patients, and providing further evidence in favour of a common pathophysiological mechanism in HH and other indomethacin-responsive primary headaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15966272

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  4 in total

1.  Hypnic headache: clinical course and treatment.

Authors:  Hans-Christoph Diener; Mark Obermann; Dagny Holle
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 2.  Hypnic headache.

Authors:  Michel Lanteri-Minet; Anne Donnet
Journal:  Curr Pain Headache Rep       Date:  2010-08

Review 3.  Focus on therapy of hypnic headache.

Authors:  Carlo Lisotto; Paolo Rossi; Cristina Tassorelli; Enrico Ferrante; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2010-06-29       Impact factor: 7.277

4.  Relapsing remitting hypnic headache responsive to indomethacin in an adolescent: a case report.

Authors:  Sanjay Prakash; Ajay S Dabhi
Journal:  J Headache Pain       Date:  2008-09-30       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.